Riociguat in Patients With Operable CTEPH Prior to Pulmonary Endarterectomy (PEA Bridging Study)

Stopped The study was stopped due to slower than expected recruitment and the additional limitations on clinical research imposed by the COVID-19 pandemic, both of which made study completion within a reasonable timeframe appear unlikely.

Conditions

• Chronic Thromboembolic Pulmonary Hypertension
• CTEPH

Interventions

• DRUG: Riociguat
• DRUG: Placebo
• PROCEDURE: Pulmonary endarterectomy

Sponsor

International CTEPH Association